lung cancer conference 2023
It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Discuss standard targeted agents in use for patients with ALK-positive non-small cell lung cancer. We're delighted to announce the launch of our 2023 conference scheduled to take place on 11 and 12 May 2023 at the Eastside Rooms, Birmingham. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences. We will also include sessions that provide a glimpse into the future of oncology, from telemedicine and social media, to mathematical models of cancer care, reflecting the innovation so closely linked to Austin. Enjoy special rates and added complimentary amenities when you book your accommodation together with your registration! European Lung Cancer Congress 2023 - ESMO There is also a lack of precise definitions of the degree of pathologic response, including Major Pathologic Response (MPR) or Complete Pathologic Response (CPR). ESMO is a Swiss-registered not-for-profit organisation. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor. The event was made possible thanks to the generous support of key sponsors, the Melbourne Convention Bureau and Business Event Victoria, whose commitment to supporting events in Victoria played a pivotal role in the conference's success. Register for WCLC 2023 Follow the IASLC on WeChat Melbourne Convention and Exhibtion Centre. Dr. Levy on Potential Methods to Optimize Molecular Testing in Lung Cancer. The schedule consists of both in-person and virtual meetings, be sure to check the access type. Join us in Singapore for the 2023 World Conference on Lung Cancerthe ultimate event for medical professionals like you. IASLC 2023 North America Conference on Lung Cancer, JTO Clinical and Research Reports (JTO CRR), IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer, Career Development and Fellowship Committee, Nurses and Allied Health Professionals Committee, Tobacco Control and Smoking Cessation Committee. Russell Kenneth Hales, MD, discusses the role of multidisciplinary care in locally advanced lung cancer. The Universal Activity Number for this program is UAN# JA4008151-0000-23-030-L05-P. Hotel arrangements can be made online at:book.passkey.com/go/MedstarHealth2023. IVBH Presents Groundbreaking Data for Early Lung Cancer Detection at This accolade recognises excellence in translational research and was awarded to Professor Sherene Loi of the Peter MacCallum Cancer Centre. Build connections with colleagues from around the world including prominent researchers and physicians. Mark A. Socinski, MD, discusses the nuances of the PACIFIC trial and ongoing research with durvalumab that could extend the reach of immunotherapy in early-stage lung cancer. ASCO Meetings Updated / Friday, 2 Jun 2023 10:37. Blood test to detect 50 types of cancer shows promise - RT A medical student with a passion for lung cancer research has been awarded the 2023 Daniel T. O'Connor, M.D. The 1st Annual Texas Lung Cancer Conference brings some of the top lung cancer experts in the nation together to discuss the latest updates and explain some of the emerging controversies in the diagnosis and management of lung cancer. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.50Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity providers responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. As more agents are evaluated either in addition to or following PD-1/PD-L1 inhibitors, more information may be learned about how best to leverage alternate biomarkers, according to Marina C. Garassino, MD. Showcase your research and contribute to discussions that will shape the future of treatments in lung cancer and thoracic malignancies. Advance Purchase and Onsite Rate August 7 to October 7, Please contact[emailprotected]or (833) 731-1273 for registrationassistance. Biomarker test results are crucial for lung cancer patients to understand, but they are difficult to read due to their complexity. From provision of educational events around the world and virtually to research projects and publications that advance the science of lung cancer, the IASLC's membersconsisting of medical, surgical, and radiation oncologists, as well as other thoracic oncology specialists such as nurses, basic scientists, pathologists, radiologists, pulmonologists, statisticians, patient research advocates, patients, and their caregiversare raising the bar for care of patients with lung cancer. Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly. Victoria , South Wharf 3006. Free oncology conference and content updates weekly. "The CSTI Conference has been a great success, and we are thrilled to have been part of this incredible event.". 2023 Upcoming Oncology Conferences | Total Health Learn more. Information for Indigenous Australians, ABN: 12 377 614 012 Rogerio C. Lilenbaum, MD, discusses some of the key clinical issues facing the lung cancer field, the role of genomic testing and multidisciplinary care, and the challenges that arose with telemedicine during the coronavirus disease 2019 pandemic. Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Fort Myers, Fla., June 1, 2023 - Florida Cancer Specialists & Research Institute, LLC (FCS) physicians are presenting the outcomes of 23 clinical trials, the majority being Phase 1, at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting on June 2 - 6 in Chicago, Illinois. MedStar Health adheres to the ACCMEs Standards for Integrity For more detailed information on the cookies we use, please check our Privacy Policy. In support of improving patient care, MedStar Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. Physicians:MedStar Health designates this live activity for a maximum of 7.50AMA PRA Category 1 Credits. The conference also served as an important platform for Australian scientists joining from the Garvan Institute, Peter Mac, WEHI, SAHMRI, ONJCRI, MCRI, Telethon Kids Institute, and the Children's Cancer Institute to showcase their latest findings. Integrate a team-based approach in the care of patients with lung cancer. TEQSA Provider ID: PRV12140, Monash University: 00008CMonash College: 01857J, Chief Marketing OfficerUniversity Marketing, Admissions and Communications, Monash Biomedicine Discovery Institute FDA approvals in recent years have started to carve out a role for immunotherapy in the frontline treatment of patients with small cell lung cancer. The Conference is an amazing opportunity to network across disciplines with other individuals in careers focused on thoracic malignancies, while learning about the latest developments in prevention, detection and care with novel data presentations. The field of nonsmall cell lung cancer has exploded with continuous advances in targeted therapies directed toward key molecular alterations, including rare mutations like MET exon 14 skipping mutations, RET rearrangements, and ROS1 mutations. IVBH. Abundance of Immunotherapy Combinations Leaves Treatment Selection Unclear in Advanced NSCLC. However, several strategies are under clinical evaluation to push the paradigm beyond the PACIFIC regimen. Lyudmila A. Bazhenova, MD, discusses future research questions with fam-trastuzumab deruxtecan-nxki in HER2-mutated lung cancer. Free registration for all healthcare providers, Expert video sessions that present the most clinically relevant data, research, and clinical strategies, Enduring video content for watching at your leisure, Virtual networking with peers, colleagues, and medical professionals, Virtual access to the latest industry information and resources, 2023 by Total Health Information Services, LLC. 2023 Targeted Therapies of Lung Cancer Meeting. mitigated prior to the commencement of the activity. Materials are available in English and Spanish. In the past 2 years, key data from clinical trials in advanced lung cancer have demonstrated that immunotherapy has expanded the bounds of the armamentarium for the treatment of several lung cancers. Dr. Hales on Investigational Treatment Strategies to Build Upon the PACIFIC Trial Results in Stage III NSCLC. PER Winter Lung Cancer Conference - OncLive IVBH Presents Groundbreaking Data for Early Lung Cancer Detection at the ASCO 2023 Annual Meeting. Medical student awarded grant to study lung cancer therapies February 7th 2023 To continue making progress in lung cancer treatment, investigators must keep pushing the science in new directions even as immunotherapy becomes more available in earlier. Lyudmila Bazhenova, MD, explores key challenges faced with diagnosing and appropriately treating patients with nonsmall cell lung cancer that harbors EGFR exon 20 insertion mutations and provides insight into the second-line options that have recently garnered regulatory approval. Industry partners: find out how to get involved. Professor Daly said, The line-up of local, national and international speakers was amazing! Explain the approved use of targeted therapy for KRAS-mutant non-small cell lung cancer. Describe current and evolving management strategies for patients with localized and locally advanced lung cancer. Recognize unique toxicities associated with targeted agents used in NSCLC. Now that a new standard of care has been established in frontline mesothelioma, clinical trials are needed to evaluate optimal sequencing with checkpoint inhibitors in the salvage setting and determine whether biomarkers of response to immunotherapy could further tailor treatment to individual patients. Tobacco use is a well-established cause of cancer and contributes to about 1 in 3 cancer deaths. This site uses cookies. This activity was planned by and for the healthcare team and learners will receive 7.50 Interprofessional Continuing Education (IPCE) credits for learning and change. 'Turning the Tide on Lung Cancer' conference highlights the importance Register free today to join the program virtually as our speakers present from Palm Beach, Florida. This map facilitates policy-level discussions drawing from real-world implementation around the world and drives a community of learning around LDCT (Low Dose Computed Tomography) screening. The latest lung cancer and thoracic malignancies research, new technologies & innovations will be presented across a 4-day in-person or virtual program. Home - WCLC 2023 All funding for this site is provided directly by ESMO. #ASCO23 Better Understanding of Biomarkers Can Inform Immunotherapy Treatment in SCLC. Immunotherapy Advances Drive Progress in Lung Cancer Treatment. All programs remain free to all healthcare providers and feature in-depth discussions on the latest in healthcare and oncology education, focusing on relevant research and strategies that directly impact patient care. Additionally, the Isabella & Marcus Foundation, a devoted philanthropic organisation spearheading research into paediatric brain cancer, stood as a longstanding partner of CSTI. Outline the clinical trial data on the use of molecular drivers in the management of patients with advanced lung cancers. We hope you enjoyed the education and the discussions. The IASLC PR Project was created to establish Pathologic Response (PR), Major Pathologic Response (MPR), and/or Complete Pathologic Response (CPR) in surgical resection specimens following neoadjuvant therapies as predictors of long-term clinical benefit in patients with resected stages I to III lung cancers. Welcome | Australian Lung Cancer Conference 2023 International Lung Cancer Congress - OncLive WCLC 2023 Early Registration Closes June 9, 2023. Latest breakthroughs in translational cancer research on show at CSTI 2023 Conference. This symposium is not certified for continuing education credit. WCLC 2022 World Conference on Lung Cancer - HealthManagement.org Gate Repeater - You have previously attended a Gate. RNA-Based NGS Offers the Potential to Identify More Patients With Rare Alterations in NSCLC. Pharmacists and Pharmacy Technicians (ACPE) Credit Designation. Repeat histologic evaluation and molecular testing in patients with EGFR-mutant nonsmall cell lung cancer who develop acquired resistance to osimertinib can deliver pertinent information that can help guide subsequent treatment decisions. 2023 Best of Lung Cancer Conference - Cvent This innovative and state of the art program will feature some of the world's leading lung cancer experts to present the latest research and strategies for the care of lung cancers incorporating data from the major oncologic annual meetings. Physicians should claim only the credit commensurate with the extent of their participation in the activity. FULL HEALINGFEST EVENT FEES. orating data from the major oncologic annual meetings. Password must be between 8 and 16 characters and contain the following: For More Details: https://medstar.cloud-cme.com/course/courseoverview?P=0&EID=26337, I am a MedStar Associate (login via SiTEL), Must be between 8 and 16 characters in length, Must Contain at least 1 upper case character, Must Contain at least 1 lower case character, Must contain at least 1 numeric character, Must contain at least 1 of the following ! Other sponsors included TrendBio, BMG Labtech, Genesearch eFreezer, NanoString, GeneWorks/Akoya, PARITY, FEBS Journal, and the Monash Partners Comprehensive Cancer Consortium. Medical oncologists, radiation oncologists, thoracic surgeons, respiratory physicians / pneumologists, interventional radiologists and pathologists, all benefited from the comprehensive programme. Investigators Set Sights Beyond the PACIFIC Regimen in Unresectable Stage III NSCLC. CARIBOU, Maine On Thursday, May 18 Cary Medical Center hosted the virtual conference "Turning the Tide on Lung Cancer" highlighting the importance of low dose CT lung cancer screening. We look forward to seeing you in Santa Monica, CA, 2022 International Association for the Study of Lung Cancer IASLC TTLC 2023 | Privacy Notice, Abstract Notifications of Acceptance/Rejection. Immunotherapy plus chemotherapy is a standard of care for patients with advanced PD-L1negative nonsmall cell lung cancer who do not harbor actionable driver mutations. Efforts to Effectively Target Rare Oncogenes Propel Progress in Lung Cancer. We have secured a roster of the top lung cancer researchers in the country, all of whom are approachable, energetic, and engaging experts. Awardee Sherene Loi (fourth from left) with Prof Roger Daly (far left), Beate Lackmann (right of Sherene) and the Co-convenors. Home - 2023 Targeted Therapies of Lung Cancer Meeting Save the date for ttlc 2024! From Awareness to Action: Championing Diversity, Equity, and Inclusion in Cancer Care, Hilton Fort Lauderdale Marina Hotel, South Florida, Cheyenne Mountain Resort Colorado Springs, 2023 by Total Health Information Services, LLC, 2023 registration is now open. TheELCC 2023will take place at the Bella Center Copenhagen, Denmark. Co-convened by Dr Antonella Papa and Associate Professors Lan Nguyen and Lee Wong from the Monash Biomedicine Discovery Institute (BDI) Cancer Program, the event showcased the latest advancements poised to revolutionise the field. As a leading medical journal, JTO focuses on lung and thoracic cancers and is dedicated to presenting original research reviews and opinions from a wide range of disciplines within the medical community. The recommendations are available in English, Spanish, Portuguese, Japanese, Chinese, and Polish. It is our great pleasure and honor to extend a warm invitation to attend and participate in the IASLC 2023 World Conference on Lung Cancer (#WCLC23) to be held in Singapore from September 9 - 12, 2023. IASLC 2023 North America Conference on Lung Cancer Upal Basu Roy, PhD, MPH, discusses the challenges of interpreting molecular testing results in lung cancer. ASH Webinar, 2023 What Changes Monday Morning? Efficacy and Safety of Abemaciclib Plus ET Is Maintained Older Patients with HR+, HER2, Early Breast Cancer, Retrospective Study Confirms Real-World Efficacy of Brexucabtagene Autoleucel in R/R B-ALL, Dr Garcia-Manero on Luspatercept in Lower-Risk MDS, Dr Zeidan on Imetelstat in Lower-risk MDS, OncLive National Fellows Forum: Lung Cancer 2023, Join us in Chicago for Giants of Cancer Care, | Join us in Chicago for Giants of Cancer Care. A section will be dedicated to optimizing multidisciplinary care for early stage and locally advanced lung cancer to include discussions on modern bronchoscopy, proton beam radiation, minimally invasive surgery and both neoadjuvant and adjuvant systemic therapy. Debate the use of targeted therapy for patients with resected EGFR mutant non-small cell lung cancer. Join us to discuss and present new and emerging data on immunoresistance in NSCLC! March 30 - April 1, 2023 ACL Live at the Moody Theater in Austin, Texas @TLCconference #TexasLung23 Endorsed by Accredited by Presented by TLC Conference Chairs We are excited to invite you to join us at the 1st Annual Texas Lung Cancer Conference in Austin, TX at the historic Austin City Limits. This innovative and state of the art program will feature some of the world's leading lung cancer experts to present the latest research and strategies for the care of lung cancers incor. 26 May 2023 Awardee Sherene Loi (fourth from left) with Prof Roger Daly (far left), Beate Lackmann (right of Sherene) and the Co-convenors. If you are interested in supporting the program, please contactElizabeth Romanoat[emailprotected]. MOC Participation Threshold There will be updates on CT screening, proper use of liquid biopsy, interpretation of molecular testing results and review of smoking cessation techniques. We invite you to join us for the 1st Annual Best of Lung Cancer conference. In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Neoadjuvant Immunotherapy Proving to Be Effective, Safe Option in Lung Cancer. 13th World Congress on Breast Cancer Research & Therapies. Dr. Raez on the Potential Utility of Cemiplimab in NSCLC. IASLC 2023 North America Conference on Lung Cancer Overview The NACLC 2023 is a dynamic meeting with a long tradition and will feature the most up-to-date research, diverse topics of interest, and educational sessions with leading experts. Please click the link below and login to watch at your convenience. In a poignant tribute, the prestigious Lackmann Award was presented by BDI Cancer Program Co-head Professor Roger Daly in honour of the late Professor Martin Lackmann. We are excited to invite you to join us at the 1st Annual Texas Lung Cancer Conference in Austin, TX at the historic Austin City Limits. You must request your certificate within 30 days of the activity to meet the deadline for submission to PARS. Exceptional Education Presentations will summarize information about ongoing clinical trials of the newest therapies for lung cancer including data on preclinical and early clinical data. Amedco LLC designates this activity for a maximum of 4.50 knowledge-based CPE contact hours. Vincent Lam, MD, describes frontline indications for this patient population, as well as strategies that can be utilized to overcome TKI resistance in later lines of therapy. Upal Basu Roy, PhD, MPH, discusses addressing barriers to biomarker testing in lung cancer. . Precision Oncology beyond EGFR/ALK for NSCLC in 2023: Test, Target, Manage, European Lung Cancer Congress 2023: Prof. Martin Reck on why you can`t miss this event, European Lung Cancer Congress 2023: Prof. Noemi Reguart on why you can`t miss this event, European Lung Cancer Congress 2023: What you can expect from this event. Amedco LLC designates this activity for a maximum of 4.50 ANCC contact hours. 2023 Texas Lung Cancer Conference - 2023 TLC Conference Welcome | Australian Lung Cancer Conference 2023 Welcome Towards 2030 - a decade of transformation in lung cancer On behalf of the Lung Foundation Australia, we warmly invite to you to be part of the 9th Australian Lung Cancer Conference to be held on the beautiful Gold Coast, Queensland from 15-17 February 2023. American Board of Internal Medicine (ABIM) MOC Credit. Attendees will have the opportunity to interact with faculty in frequent Q&A sessions with access to presentation materials for later review.
Vanuatu Company Search,
Sukin Purely Ageless Reviving Eye Cream,
Articles L